Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
HIV Clin Trials ; 13(3): 131-41, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22592093

RESUMO

BACKGROUND: We analyzed differences in response to combined antiretroviral therapy (cART) according to sex and geographic origin in a retrospective comparative study of Spanish-born and immigrant patients initiating cART. METHODS: The primary endpoint was time to treatment failure (TTF), defined as virological failure, death, opportunistic infection, interruption of cART, or loss to follow-up. Late diagnosis was defined as a CD4+ cell count ≤ 200 cells/mm3 and/or AIDS at initiation of cART. Survival was analyzed using Kaplan-Meier analysis and Cox regression. RESULTS: We followed 1,090 patients, of whom 318 were women (45.6% immigrant women [IW]). At initiation of treatment, women had a higher CD4+ count than men (217 vs 190 cells/mm3), a lower viral load (4.7 vs 5 log), and fewer were late starters (49% vs 59%). The adjusted risk of TTF between women and men was not significantly different (hazard ratio [HR], 1.10; 95% CI, 0.79-1.53). TTF was shorter among IW than Spanish-born women (124 weeks [95% CI, 64-183] vs 151 [95% CI, 127-174]) and loss to follow-up was double that of Spanish-born women (25.5% vs 11.6%). CONCLUSIONS: Although response to cART was similar for both sexes, men started treatment later. IW were more frequently lost to follow-up and switched treatment. Measures to improve medical follow-up after initiation of cART should be promoted among this minority group.


Assuntos
Fármacos Anti-HIV/administração & dosagem , Infecções por HIV/tratamento farmacológico , Adulto , Contagem de Linfócito CD4 , Estudos de Coortes , Quimioterapia Combinada , Emigrantes e Imigrantes , Feminino , Infecções por HIV/imunologia , Infecções por HIV/mortalidade , Infecções por HIV/virologia , Humanos , Masculino , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Caracteres Sexuais , Espanha , Fatores de Tempo , Falha de Tratamento
3.
Enferm Infecc Microbiol Clin ; 26 Suppl 5: 6-11, 2008 May.
Artigo em Espanhol | MEDLINE | ID: mdl-18590661

RESUMO

The clinical manifestations of HIV infection vary widely in distinct geographical areas. While HIV-related disease has been well characterized in western countries, relatively few publications have described the clinical manifestations of these diseases in tropical areas, where the vast majority of HIV-infected people are concentrated. In addition, HIV infection may alter the natural history of tropical diseases in several ways and tropical diseases influence the course of HIV infection. The present review describes the major opportunistic infections afflicting people with HIV/AIDS in Africa, Latin America, and Asia and discusses the mutual interactions between HIV and the major tropical diseases.


Assuntos
Infecções por HIV/diagnóstico , África , Ásia , Região do Caribe , Saúde Global , Infecções por HIV/complicações , Humanos , América Latina
5.
Rev Esp Quimioter ; 29(1): 15-24, 2016 Feb.
Artigo em Espanhol | MEDLINE | ID: mdl-26875567

RESUMO

OBJECTIVE: Infectious complications are an important cause of morbidity and mortality in haematological patients with febrile neutropenia. The aim of this study was to develop a consensus document of recommendations to optimize the management of febrile neutropenic patients with haematological or vascular catheter infections in areas where there is no solid scientific evidence. METHODS: After reviewing the scientific evidence, a scientific committee composed of experts in haematology and infectious diseases developed a survey with 55 statements. A two- round modified Delphi method was used to achieve consensus. RESULTS: The online survey was answered by 52 experts in the field of haematology and infectious diseases. After two rounds of evaluation, a consensus was possible in 43 of the 55 statements (78.2%): 40 in agreement and 3 in disagreement. Recommendations are given related to empirical antibiotic treatment of patients with febrile neutropenia, mechanisms of action, toxicity and synergism of antibiotics in this context, modifications of antibiotic treatment in the course of febrile neutropenia, and the management of central vascular catheter infections in the haematological setting. CONCLUSIONS: There is a high degree of agreement among experts on some controversial issues concerning the management of febrile neutropenia and catheter infection in hematologic patients. This agreement has resulted in recommendations that may be useful in clinical practice.


Assuntos
Bacteriemia/terapia , Infecções Relacionadas a Cateter/terapia , Doenças Hematológicas/complicações , Posicionamento do Paciente , Antibacterianos/uso terapêutico , Anti-Infecciosos/uso terapêutico , Bacteriemia/tratamento farmacológico , Infecções Relacionadas a Cateter/tratamento farmacológico , Consenso , Técnica Delphi , Sinergismo Farmacológico , Quimioterapia Combinada , Pesquisas sobre Atenção à Saúde , Doenças Hematológicas/terapia , Humanos , Neutropenia/tratamento farmacológico , Neutropenia/etiologia
6.
Enferm Infecc Microbiol Clin ; 26(9): 558-60, 2008 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-19100175

RESUMO

Initially described in travelers, outbreaks of cyclosporiasis were soon linked to imported food products. An outbreak of cyclosporiasis in Spanish travelers is described. After identification of Cyclospora cayetanensis in stool analyses, a specific questionnaire was completed. Pyrosis was described in 57% of cases (4/7). Peptic symptoms can be a useful clue to indicate the diagnosis of cyclosporiasis in patients with travelers' diarrhea.


Assuntos
Ciclosporíase/epidemiologia , Diarreia/etiologia , Surtos de Doenças , Contaminação de Alimentos , Parasitologia de Alimentos , Viagem , Adulto , Animais , Cuba/epidemiologia , Cyclospora/isolamento & purificação , Ciclosporíase/tratamento farmacológico , Ciclosporíase/transmissão , Diarreia/parasitologia , Feminino , Azia/tratamento farmacológico , Azia/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Espanha , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
7.
J Acquir Immune Defic Syndr ; 41(2): 154-9, 2006 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-16394846

RESUMO

OBJECTIVE: To analyze the safety and effectiveness of abacavir, lamivudine, and zidovudine (ABC/3TC/ZDV) in antiretroviral therapy (ART)-naive HIV-infected patients. DESIGN: Retrospective observational cohort study. METHODS: We analyzed all consecutive ART-naive HIV-infected patients who initiated ABC/3TC/ZDV in 71 centers throughout Spain and had a clinical visit and laboratory data at least 16 weeks after initiating this regimen. We assessed safety, mortality, new AIDS-defining conditions (ADCs) and treatment failure, the latter defined by any of the following: (1) reduction in plasma HIV-1 viral load (pVL) <1 log during the first 12 weeks of ART, unless it was less than the lower limit of quantification (LOQ); (2) failure to achieve a pVL or = LOQ after achieving a pVL

Assuntos
Fármacos Anti-HIV/uso terapêutico , Didesoxinucleosídeos/uso terapêutico , Infecções por HIV/tratamento farmacológico , HIV-1 , Lamivudina/uso terapêutico , Zidovudina/uso terapêutico , Adulto , Fármacos Anti-HIV/efeitos adversos , Estudos de Coortes , Didesoxinucleosídeos/efeitos adversos , Quimioterapia Combinada , Feminino , Humanos , Hipersensibilidade/etiologia , Lamivudina/efeitos adversos , Masculino , Cooperação do Paciente , Estudos Retrospectivos , Espanha , Falha de Tratamento , Zidovudina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA